• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增生型糖尿病性视网膜病变玻璃体腔注射贝伐单抗后纤维血管膜的组织学。

Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.

机构信息

Department of Ophthalmology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.

出版信息

Retina. 2010 Mar;30(3):468-72. doi: 10.1097/IAE.0b013e3181bd2d7b.

DOI:10.1097/IAE.0b013e3181bd2d7b
PMID:19952991
Abstract

PURPOSE

The purpose was to study the histology of the fibrovascular membranes in proliferative diabetic retinopathy (PDR) with an intravitreal injection of bevacizumab.

METHODS

Light and electron microscopic studies were performed on surgical specimens obtained during a pars plana vitrectomy from 6 PDR eyes after intravitreal injection of bevacizumab. The patients had preoperatively received no or scant retinal photocoagulations. The presence and distribution of CD34 was assessed as a marker of vascular endothelium using immunostaining. The presence of vascular endothelial growth factor was stained with a method of immunostaining. As controls, we examined 7 surgical specimens from 7 PDR eyes obtained during pars plana vitrectomy without bevacizumab therapy. All control patients had preoperatively received full or nearly full pan retinal photocoagulations.

RESULTS

Light microscopy showed that the CD34-positive vascular endothelial cells formed capillarylike structures in the fibrovascular membranes of all 13 PDR eyes. Vascular endothelial growth factor was positively stained in the vascular endothelium of both groups; however, the number of vascular endothelial growth factor-positive vascular endothelial cells significantly decreased in the fibrovascular membranes with intravitreal injection of bevacizumab. Electron microscopy showed the newly formed vascular endothelial cells with junctional complex in both groups.

CONCLUSION

The vascular endothelial cells with decreased expression of vascular endothelial growth factor are still present in the fibrovascular membranes of patients with PDR after intravitreal injection of bevacizumab.

摘要

目的

本研究旨在通过玻璃体腔注射贝伐单抗,研究增生性糖尿病视网膜病变(PDR)的纤维血管膜的组织学特征。

方法

对 6 例接受玻璃体腔注射贝伐单抗的 PDR 患者行玻璃体切割术获得的手术标本进行光镜和电镜检查。所有患者术前均未接受或仅接受少量视网膜光凝治疗。采用免疫组化法检测 CD34 的表达,评估其作为血管内皮标志物的存在和分布。采用免疫组化法检测血管内皮生长因子的存在。作为对照,我们还检查了 7 例接受玻璃体切割术但未接受贝伐单抗治疗的 PDR 患者的 7 例手术标本。所有对照患者术前均接受了全视网膜或近乎全视网膜光凝治疗。

结果

光镜下,所有 13 例 PDR 眼的纤维血管膜中 CD34 阳性的血管内皮细胞形成毛细血管样结构。两组的血管内皮均呈血管内皮生长因子阳性染色,但玻璃体腔注射贝伐单抗后,纤维血管膜中血管内皮生长因子阳性的血管内皮细胞数量明显减少。电镜下,两组均可见到表达血管内皮生长因子减少的新生血管内皮细胞。

结论

玻璃体腔注射贝伐单抗后,PDR 患者的纤维血管膜中仍存在表达血管内皮生长因子减少的血管内皮细胞。

相似文献

1
Histology of fibrovascular membranes of proliferative diabetic retinopathy after intravitreal injection of bevacizumab.增生型糖尿病性视网膜病变玻璃体腔注射贝伐单抗后纤维血管膜的组织学。
Retina. 2010 Mar;30(3):468-72. doi: 10.1097/IAE.0b013e3181bd2d7b.
2
Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.玻璃体内和血浆中血管紧张素原肽和血管内皮生长因子在增生性糖尿病视网膜病变眼内注射bevacizumab 后的浓度。
Retina. 2011 Jan;31(1):161-8. doi: 10.1097/IAE.0b013e3181e46ad8.
3
Fibrous membranes in diabetic retinopathy and bevacizumab.糖尿病性视网膜病变和贝伐单抗中的纤维膜。
Retina. 2010 Jul-Aug;30(7):1012-6. doi: 10.1097/IAE.0b013e3181cb463a.
4
Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.玻璃体腔注射贝伐单抗治疗增殖性糖尿病视网膜病变玻璃体切除术后玻璃体积血后发生的幽灵细胞性青光眼。
Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):72-7. doi: 10.3928/15428877-20091230-13.
5
Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者眼内注射贝伐单抗或曲安奈德后的玻璃体介质
Ophthalmology. 2009 May;116(5):921-6. doi: 10.1016/j.ophtha.2008.12.024.
6
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.微创玻璃体切除术联合玻璃体内注射贝伐单抗作为手术辅助治疗糖尿病性牵拉性视网膜脱离。
Ophthalmology. 2009 May;116(5):927-38. doi: 10.1016/j.ophtha.2008.11.005. Epub 2009 Mar 9.
7
Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.玻璃体内注射贝伐单抗预防糖尿病患者玻璃体切除术后早期出血:一项随机临床试验。
Ophthalmology. 2009 Oct;116(10):1943-8. doi: 10.1016/j.ophtha.2009.07.001. Epub 2009 Aug 21.
8
Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications.术前玻璃体内使用贝伐单抗作为糖尿病玻璃体切除术的辅助治疗:组织病理学发现和临床意义。
Ophthalmology. 2011 Apr;118(4):636-41. doi: 10.1016/j.ophtha.2010.08.038. Epub 2010 Nov 4.
9
Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy.对于严重增殖性糖尿病视网膜病变,更倾向于使用玻璃体内注射贝伐单抗作为玻璃体切除术的预处理。
Eye (Lond). 2009 Jan;23(1):108-11. doi: 10.1038/sj.eye.6702983. Epub 2007 Sep 21.
10
Altered vascular microenvironment by bevacizumab in diabetic fibrovascular membrane.贝伐珠单抗改变糖尿病性纤维血管膜中的血管微环境。
Retina. 2013 May;33(5):957-63. doi: 10.1097/IAE.0b013e3182753b41.

引用本文的文献

1
Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy.术前抗血管内皮生长因子对增殖性糖尿病视网膜病变纤维血管膜血管生成和纤维化特征的短期影响
Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):37. doi: 10.1167/iovs.65.4.37.
2
Cell-Matrix Interactions in the Eye: From Cornea to Choroid.眼睛中的细胞-基质相互作用:从角膜到脉络膜。
Cells. 2021 Mar 20;10(3):687. doi: 10.3390/cells10030687.
3
Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.
应用 OCT 血管造影观察增生性糖尿病视网膜病变眼内注康柏西普后视盘新生血管
Sci Rep. 2018 Mar 5;8(1):3972. doi: 10.1038/s41598-018-22363-0.
4
APOPTOSIS AND ANGIOFIBROSIS IN DIABETIC TRACTIONAL MEMBRANES AFTER VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITION: Results of a Prospective Trial. Report No. 2.血管内皮生长因子抑制后糖尿病牵引性膜中的细胞凋亡和血管纤维瘤形成:一项前瞻性试验的结果。报告 2 号。
Retina. 2019 Feb;39(2):265-273. doi: 10.1097/IAE.0000000000001952.
5
Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.增殖性糖尿病视网膜病变患者来源的纤维血管膜细胞的特征分析
Mol Vis. 2015 Jun 12;21:673-87. eCollection 2015.
6
Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.控制贝伐单抗(阿瓦斯汀)抑制早期而非晚期形成的角膜新生血管作用的机制。
PLoS One. 2014 Apr 8;9(4):e94205. doi: 10.1371/journal.pone.0094205. eCollection 2014.
7
Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy.体外培养人增生性糖尿病视网膜病变的视网膜前膜细胞的功能和分子特征。
Biomed Res Int. 2013;2013:492376. doi: 10.1155/2013/492376. Epub 2013 Oct 1.
8
Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α.贝伐单抗对增殖性糖尿病视网膜病变新生血管膜的影响:内皮细胞减少以及血管内皮生长因子(VEGF)和缺氧诱导因子-1α(HIF-1α)表达降低。
Mol Vis. 2012;18:1-9. Epub 2012 Jan 1.
9
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability.用于眼部血管生成和血管通透性的抗血管内皮生长因子药物
J Ophthalmol. 2012;2012:852183. doi: 10.1155/2012/852183. Epub 2011 Nov 3.
10
Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection.玻璃体内注射贝伐单抗后增殖性糖尿病视网膜病变中纤维血管膜的逆行模式成像。
Clin Ophthalmol. 2011;5:897-900. doi: 10.2147/OPTH.S22843. Epub 2011 Jun 30.